Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans

NCT00189202 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

End Stage Renal Disease
Kidney Transplantation

Interventions

DRUG: Sirolimus

Sponsor

University of Michigan

Collaborators

[object Object]